HomeOpen Access NewsContributor Profile

Contributor Profile

Social housing retrofit: Navigating net zero

With tighter energy efficiency targets in place and a broader UK commitment to 2050 net zero, selecting the best roadmap to low-carbon heat can feel daunting for social housing providers. Rob Pearse, Residential Business Director at Baxi, outlines some of the options.

Agriculture focus: Legumes contribute to a better world

Roger Vickers, CEO of the Processors and Growers Research Organisation explains the LegValue project and how in the world of agriculture, legumes contribute to a better world.

How can biomaterials-based technologies treat vision disorders?

Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.

Cytochromes P450: Chemistry for drugs, metabolism, and beyond

Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.

The export of medicinal cannabis from Israel

Kathleen Denoodt shares with us what we need to know about the export of medicinal cannabis from Israel.

Gyrase and topoisomerase IV: Repurposing old targets for new antibacterials

Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.

Is there a case for differentiated longevity adjustment of the retirement age?

Professors of Economics Svend E. Hougaard Jensen and Gylfi Zoega call for public-private partnership as they discuss adjustments of the retirement age and pension funds according to life expectancy.

Accelerating the electric vehicle industry’s dynamic and continuous transformation

Here, we find out how Driivz delivers an intelligent electric vehicle (EV) charging management solution, optimizing operations, energy management, network monetisation and customer satisfaction.

Electric cars and buses: The principal transport mode of the future?

Dr Robert Carpenter, MD of Inside2Outside Ltd, provides a detailed insight into electric cars and buses which he argues will be the principal mode of transport soon.

The leadership challenge of COP26, 2021

Richard Beardsworth, Professor and Head of School, School of Politics and International Studies, University of Leeds, addresses the leadership challenge of COP26, 2021.

Social value in a post-COVID-19 world

Social Value Portal discusses how rethinking social value priorities to reflect the current and future challenges of COVID-19 is crucial for sustainable social value.

Cannabinoids in medicine part 5: Treating COVID-19

In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.

A compliance verification package for end-to-end delivery of COVID-19 test kits

Genevieve Leveille, CEO of UK firm 08 Group and Co-Chair of the TechUK DLT Working Group, collaborates with digital health tech companies to deliver verified-safe China-sourced Covid-19 test kits at scale.

Oncology: Imaging biomarkers and the Alberta Radiopharmaceutical Collaboration

Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.

Are bio-based solutions in the automotive industry the way forward?

Michal Skwierczyński, Coordinator of the BioMotive project, explores the benefits of bio-based solutions for both automotive and wider industries post COVID-19.

SEA-TITAN: Wave energy technology convergence

Aleix Maria Arenas from Wedge Global tells us what we need to know about the H2020-funded SEA-TITAN project that encourages a step-change towards wave energy technology convergence.

Enduring research: The constant threat of influenza virus outbreaks

Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders